• Mezzion Pharma CEO Park Dong-hyun bought 1,940 common shares on Oct. 29, 2026, raising his holding to 1,860,263 shares.
• His ownership stake remained at 6.02%. The open-market purchases averaged KRW 51,537 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mezzion Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000091), on October 29, 2026, and is solely responsible for the information contained therein.